Sign inCreate account

Report workspace

Add to folder
NCT03695289COMPLETEDanonymous

Adaptation of an Evidence-based Interactive Obesity Treatment Approach (iOTA) for Obesity Prevention in Serious Mental Illness

Sponsor

Source record

Washington University School of Medicine

Phase

Source record

Not Applicable

Modality

AI-normalized

behavioral intervention

Target

AI-normalized

The intervention targets behavioral modifications related to obesity management in adults with serious mental illness (SMI), focusing on diet, physical activity, and medication adherence through an interactive approach.

Indication / condition

AI-normalized

Obesity

Intervention

Source record

iOTA SMI, Health Education Control

Source & freshness

Source record

NCT ID

NCT03695289

Original source

ClinicalTrials.gov

Source last updated

Jul 16, 2020

Ingested at

Jun 16, 2026

Internal sync

Jun 16, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT03695289

Title

Adaptation of an Evidence-based Interactive Obesity Treatment Approach (iOTA) for Obesity Prevention in Serious Mental Illness

Sponsor

Washington University School of Medicine

Status

COMPLETED

Phase

Not Applicable

Condition raw

Obesity, Mentally Ill Persons

Condition normalized

Obesity, Mentally Ill Persons

Modality raw

behavioral intervention

Modality normalized

behavioral intervention

Target raw

The intervention targets behavioral modifications related to obesity management in adults with serious mental illness (SMI), focusing on diet, physical activity, and medication adherence through an interactive approach.

Target normalized

The intervention targets behavioral modifications related to obesity management in adults with serious mental illness (SMI), focusing on diet, physical activity, and medication adherence through an interactive approach.

Interventions

iOTA SMI, Health Education Control

Public preview

Source record

The iOTA-SMI program represents a novel approach to obesity management in a high-need population, addressing a significant gap in effective treatments for obesity among individuals with serious mental illness. Given the high prevalence of obesity in this demographic and the lack of FDA-approved pharmacotherapies, the program could capture a unique market segment. The competitive landscape includes traditional behavioral interventions and off-label pharmacotherapies, which have shown limited effectiveness. The scalability and adaptability of the iOTA-SMI program may enhance its attractiveness for potential partnerships or funding opportunities, particularly in community mental health settings. Future effectiveness testing and large-scale dissemination could further validate its commercial viability.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Adaptation of an Evidence-based Interactive Obesity Treatment Approach (iOTA) for Obesity Prevention in Serious Mental Illness

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 16, 2026

NCT ID

NCT03695289

Status

COMPLETED

Phase

Not Applicable

Sponsor

Washington University School of Medicine

Executive brief

Investment-Ready Snapshot

The iOTA-SMI program represents a novel approach to obesity management in a high-need population, addressing a significant gap in effective treatments for obesity among individuals with serious mental illness. Given the high prevalence of obesity in this demographic and the lack of FDA-approved pharmacotherapies, the program could capture a unique market segment. The competitive landscape includes traditional behavioral interventions and off-label pharmacotherapies, which have shown limited effectiveness. The scalability and adaptability of the iOTA-SMI program may enhance its attractiveness for potential partnerships or funding opportunities, particularly in community mental health settings. Future effectiveness testing and large-scale dissemination could further validate its commercial viability.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedJul 16, 2020
Internal syncJun 16, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT03695289

Indication

Obesity

Modality

behavioral intervention

Target

The intervention targets behavioral modifications related to obesity management in adults with serious mental illness (SMI), focusing on diet, physical activity, and medication adherence through an interactive approach.

Intervention

iOTA SMI, Health Education Control

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.